Sep 22, 2026 07:01AM
Sep 22, 2026 07:00AM
Aug 6, 2026 08:00AM
Jul 13, 2026 08:30AM
Jul 13, 2026 08:30AM
Jun 17, 2026 05:30AM
Jun 16, 2026 10:18AM Biotech Bulls Stampede as Clinical Wins and Milestones Fuel Momentum
Jun 16, 2026 07:00AM
Jun 16, 2026 07:00AM
Jun 1, 2026 08:31AM
Jun 1, 2026 08:30AM
May 7, 2026 08:00AM
Mar 10, 2026 07:02AM
Mar 10, 2026 07:00AM Edgewise Announces Positive Long-Term Sevasemten Data Demonstrating Sustained Functional Stabilization in Becker Muscular Dystrophy Through 3.5 Years of Follow-Up
Mar 3, 2026 08:00AM
Feb 26, 2026 08:00AM
Jan 13, 2026 08:00AM
Dec 24, 2025 08:00AM
Dec 24, 2025 08:00AM
Dec 22, 2025 07:06AM
Nov 20, 2025 08:00AM Edgewise Therapeutics adds Christopher Martin to board of directors
Nov 20, 2025 08:00AM
Nov 10, 2025 08:01AM
Nov 10, 2025 08:00AM
Nov 6, 2025 08:00AM
Oct 2, 2025 08:00AM
Sep 11, 2025 08:18AM
Aug 8, 2025 08:43AM Edgewise Therapeutics (EWTX) PT Raised to $49 at RBC Capital
Aug 7, 2025 10:44AM
Aug 7, 2025 08:00AM
Jul 3, 2025 10:00AM
Jul 1, 2025 10:00AM
Jun 28, 2025 10:00AM
Jun 26, 2025 10:32AM
Jun 26, 2025 06:00AM Edgewise Therapeutics Inc. (EWTX) Reports Positive Results on Sevasemten Program
Jun 26, 2025 06:00AM
Jun 11, 2025 08:35AM
Jun 5, 2025 08:53AM
May 8, 2025 08:00AM
Mar 11, 2025 08:00AM
Mar 10, 2025 09:44AM
Mar 3, 2025 08:00AM Edgewise Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Jan 13, 2025 12:50PM
Jan 13, 2025 08:00AM
Jan 2, 2025 12:51PM
Dec 16, 2024 06:05AM
Dec 16, 2024 06:00AM
Dec 5, 2024 02:32PM
Dec 5, 2024 02:32PM Edgewise Provides Statement Regarding Company’s Relationship with Dr. Han Phan at Rare Disease Research
Dec 5, 2024 01:02PM

331,653 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All